Kempner Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $3.39M | Sell |
33,776
-2,845
| -8% | -$267K | 3.2% | 8 |
|
|
2025
Q3 | $3.07M | Sell |
36,621
-31,785
| -46% | -$2.62M | 2.56% | 17 |
|
|
2025
Q2 | $5.42M | Buy |
68,406
+1,778
| +3% | +$141K | 2.9% | 12 |
|
|
2025
Q1 | $5.98M | Buy |
66,628
+36,658
| +122% | +$3.42M | 3.37% | 8 |
|
|
2024
Q4 | $2.98M | Buy |
+29,970
| New | +$3.09M | 1.64% | 32 |
|
|
2022
Q3 | – | Sell |
-40,039
| Closed | -$3.65M | – | 64 |
|
|
2022
Q2 | $3.65M | Sell |
40,039
-13,467
| -25% | -$1.19M | 2.22% | 19 |
|
|
2022
Q1 | $4.39M | Buy |
53,506
+115
| +0.2% | +$9.07K | 2.4% | 15 |
|
|
2021
Q4 | $4.09M | Buy |
53,391
+13,478
| +34% | +$1.07M | 2.41% | 17 |
|
|
2021
Q3 | $3M | Hold |
39,913
| – | – | 1.71% | 24 |
|
|
2021
Q2 | $3.1M | Sell |
39,913
-1,916
| -5% | -$143K | 1.76% | 23 |
|
|
2021
Q1 | $3.08M | Hold |
41,829
| – | – | 1.77% | 25 |
|
|
2020
Q4 | $3.27M | Hold |
41,829
| – | – | 2.16% | 20 |
|
|
2020
Q3 | $3.31M | Hold |
41,829
| – | – | 2.65% | 15 |
|
|
2020
Q2 | $3.09M | Sell |
41,829
-92
| -0.2% | -$6.93K | 2.42% | 18 |
|
|
2020
Q1 | $3.08M | Buy |
41,921
+1,897
| +5% | +$149K | 2.68% | 16 |
|
|
2019
Q4 | $3.47M | Sell |
40,024
-69
| -0.2% | -$5.67K | 2.25% | 21 |
|
|
2019
Q3 | $3.22M | Sell |
40,093
-13,345
| -25% | -$1.07M | 2.18% | 23 |
|
|
2019
Q2 | $4.28M | Sell |
53,438
-17,795
| -25% | -$1.36M | 2.8% | 16 |
|
|
2019
Q1 | $5.65M | Sell |
71,233
-17,892
| -20% | -$1.34M | 3.73% | 7 |
|
|
2018
Q4 | $6.5M | Hold |
89,125
| – | – | 4.47% | 3 |
|
|
2018
Q3 | $6.03M | Sell |
89,125
-46
| -0.1% | -$2.93K | 3.87% | 6 |
|
|
2018
Q2 | $5.17M | Sell |
89,171
-26
| -0% | -$1.47K | 3.4% | 8 |
|
|
2018
Q1 | $4.64M | Buy |
89,197
+20,148
| +29% | +$1.09M | 3.16% | 13 |
|
|
2017
Q4 | $3.71M | Buy |
69,049
+46,979
| +213% | +$2.6M | 2.32% | 20 |
|
|
2017
Q3 | $1.35M | Buy |
22,070
+426
| +2% | +$25.8K | 0.89% | 31 |
|
|
2017
Q2 | $1.32M | Buy |
21,644
+181
| +0.8% | +$11K | 0.87% | 34 |
|
|
2017
Q1 | $1.3M | Buy |
21,463
+1,043
| +5% | +$63.3K | 0.87% | 31 |
|
|
2016
Q4 | $1.15M | Sell |
20,420
-2,096
| -9% | -$123K | 0.83% | 32 |
|
|
2016
Q3 | $1.34M | Sell |
22,516
-24,401
| -52% | -$1.43M | 0.92% | 34 |
|
|
2016
Q2 | $2.58M | Hold |
46,917
| – | – | 1.66% | 27 |
|
|
2016
Q1 | $2.37M | Hold |
46,917
| – | – | 1.42% | 30 |
|
|
2015
Q4 | $2.37M | Sell |
46,917
-2,268
| -5% | -$114K | 1.39% | 31 |
|
|
2015
Q3 | $2.32M | Hold |
49,185
| – | – | 1.31% | 36 |
|
|
2015
Q2 | $2.67M | Buy |
49,185
+9,432
| +24% | +$529K | 1.39% | 34 |
|
|
2015
Q1 | $2.18M | Sell |
39,753
-30,091
| -43% | -$1.7M | 1.38% | 30 |
|
|
2014
Q4 | $3.79M | Hold |
69,844
| – | – | 1.7% | 28 |
|
|
2014
Q3 | $3.95M | Sell |
69,844
-3,563
| -5% | -$200K | 1.68% | 31 |
|
|
2014
Q2 | $4.05M | Hold |
73,407
| – | – | 1.6% | 28 |
|
|
2014
Q1 | $3.98M | Sell |
73,407
-498
| -0.7% | -$25.8K | 1.61% | 28 |
|
|
2013
Q4 | $3.53M | Buy |
+73,905
| New | +$3.38M | 1.5% | 30 |
|
Other funds holding MRK
Kempner Capital Management's MRK Position: Q4 2025 in Review
Kempner Capital Management reduced its Merck (MRK) stake by 7.8% in Q4 2025, selling an estimated $267K and leaving 33,776 shares worth $3.39M. The position accounts for 3.2% of the portfolio, ranked #8.
Kempner Capital Management first reported a position in MRK in Q4 2013 and has held it in 40 quarters since. The position peaked at $6.5M in Q4 2018. 3,652 funds tracked by Wall St. Rank hold MRK as of Q4 2025.
- Kempner Capital Management held 33,776 shares of Merck worth $3.39M as of Q4 2025.
- Kempner Capital Management sold 2,845 Merck shares in Q4 2025, an estimated $267K.
- Merck made up 3.2% of Kempner Capital Management's portfolio in Q4 2025, its #8 holding.
- Kempner Capital Management first reported a position in Merck in Q4 2013 and has held it in 40 quarters since.
- Kempner Capital Management's Merck position peaked at $6.5M in Q4 2018.
- 3,652 funds tracked by Wall St. Rank held Merck as of Q4 2025.
Based on Kempner Capital Management's 13F filing for Q4 2025, filed 12 Jan 2026.